Diabetes And CNS Treatment See Double-Digit Growth In Japan: IMS
This article was originally published in PharmAsia News
Executive Summary
Diabetic drug sales increased 17.8% while dementia treatment grew 13.8% in Japan, according to a recent IMS Japan report.